US Point-of-Care/POC Hematology and Flow Cytometry Markets: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers--Supplier Shares, Competitive Strategies, Country Segment Forecasts, Innovative Technologies, Instrumentation Review
This new 238-page report from VPGMarketResearch.com contains 38 tables, and provides a comprehensive analysis of the POC hematology and flow cytometry market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC hematology and flow cytometry market.
INTRODUCTION
Executive Summary
Rationale for Testing Decentralization
1. OVERVIEW
2. REGULATORY TRENDS
3. ECONOMIC TRENDS
4. DEMOGRAPHIC TRENDS
5. TECHNOLOGICAL TRENDS
6. SOCIAL TRENDS
7. QUALITY OF CARE
8. DEFENSIVE MEDICINE
9. QUALITY CONTROL ISSUES
Major Routine and Special Hematology Tests
1. CBC ANALYSIS
a. Hemoglobin Concentration
b. Hematocrit Determination
c. Red Blood Cell Count
d. Platelets
Instrumentation: Hematology Analyzers Manufactured by:
Abbott
Becton Dickinson
Beckman Coulter/Danaher
Biocode
DrewScientific
Diesse Ves Matic
Horiba
Menarini
Nihon Kohden
Polymedco
Sysmex
Current and Emerging Technologies
1. MONOCLONAL ANTIBODIES
2. IMMUNOASSAYS
a. Technological Principle
b. Enzyme Immunoassays (EIA)
Overview
ELISA
Dot Immunobinding Assays
Capillary Immunoassays
ParticleMembrane Capture Immunoassay
Enzyme Amplification
c. Fluorescent Immunoassays
Fluorescent Polarization
TimeResolved Pulse Fluorescence
d. Luminescence
Chemiluminescence
Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
3. DRY CHEMISTRY
4. BIOSENSORS
5. IT AND AUTOMATION
6. MOLECULAR DIAGNOSTICS
a. Technology Overview
b. Amplification Methods
Polymerase Chain Reaction
Ligase Chain Reaction
Branched DNA
QBeta Replicase
Strand Displacement Activation
SelfSustained Sequence Replicase
U.S.A. A. Market Overview
1. BUSINESS ENVIRONMENT
a. Health Care Expenditures
b. Cost Consciousness
c. Reimbursement
d. Industry Consolidation
e. Managed Care
PPO
HMO
f. Hospitals
g. Admissions
h. Length of Stay
i. Industry Diversification
j. Physician Demographics
k. Aging Population
More Chronic Illness
Disease Incidence
Susceptibility to latrogenesis
Multiple Illnesses Cases
l. Laboratory Regulations
2. MARKET STRUCTURE
a. Hospitals
b. Commercial/Private Laboratories
B. Physician Offices/Group Practices
1. MARKET SUMMARY
2. MARKET STRUCTURE
3. TEST VOLUME AND SALES FORECASTS
C. Ancillary Hospital Locations
1. INTRODUCTION
a. Emergency Departments
b. Operating Suites
c. Intensive Care Units
2. EMERGENCY DEPARTMENTS
a. Market Summary
b. Test volume and Sales Forecasts
3. OPERATING AND RECOVERY SUITES
a. Market Summary
b. Test Volume and Sales Forecasts
4. ICUS/CCUS
a. Market Summary
b. Test Volume and Sales Forecasts
D. Cancer Clinics 1. INTRODUCTION
2. MARKET SUMMARY
3. TEST VOLUME AND SALES FORECASTS
E. Ambulatory Care Centers 1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
F. Surgery Centers
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
G. Nursing Homes
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
H. Birth Centers
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
I. Major Suppliers’ Instrument Placements, Installed Base, Instrument and Consumables Sales, and Market Shares
MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
TESTING MARKETS
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Company Profile
Abbott
Agilent Technologies
Beckman Coulter/Danaher
Becton Dickinson
BioRad
CellaVision
Horiba
Iris Diagnostics/Danaher
Nihon Kohden
OrthoClinical Diagnostics
Roche
Siemens
Sysmex
Executive Summary
Rationale for Testing Decentralization
1. OVERVIEW
2. REGULATORY TRENDS
3. ECONOMIC TRENDS
4. DEMOGRAPHIC TRENDS
5. TECHNOLOGICAL TRENDS
6. SOCIAL TRENDS
7. QUALITY OF CARE
8. DEFENSIVE MEDICINE
9. QUALITY CONTROL ISSUES
Major Routine and Special Hematology Tests
1. CBC ANALYSIS
a. Hemoglobin Concentration
b. Hematocrit Determination
c. Red Blood Cell Count
d. Platelets
Instrumentation: Hematology Analyzers Manufactured by:
Abbott
Becton Dickinson
Beckman Coulter/Danaher
Biocode
DrewScientific
Diesse Ves Matic
Horiba
Menarini
Nihon Kohden
Polymedco
Sysmex
Current and Emerging Technologies
1. MONOCLONAL ANTIBODIES
2. IMMUNOASSAYS
a. Technological Principle
b. Enzyme Immunoassays (EIA)
Overview
ELISA
Dot Immunobinding Assays
Capillary Immunoassays
ParticleMembrane Capture Immunoassay
Enzyme Amplification
c. Fluorescent Immunoassays
Fluorescent Polarization
TimeResolved Pulse Fluorescence
d. Luminescence
Chemiluminescence
Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
3. DRY CHEMISTRY
4. BIOSENSORS
5. IT AND AUTOMATION
6. MOLECULAR DIAGNOSTICS
a. Technology Overview
b. Amplification Methods
Polymerase Chain Reaction
Ligase Chain Reaction
Branched DNA
QBeta Replicase
Strand Displacement Activation
SelfSustained Sequence Replicase
U.S.A. A. Market Overview
1. BUSINESS ENVIRONMENT
a. Health Care Expenditures
b. Cost Consciousness
c. Reimbursement
d. Industry Consolidation
e. Managed Care
PPO
HMO
f. Hospitals
g. Admissions
h. Length of Stay
i. Industry Diversification
j. Physician Demographics
k. Aging Population
More Chronic Illness
Disease Incidence
Susceptibility to latrogenesis
Multiple Illnesses Cases
l. Laboratory Regulations
2. MARKET STRUCTURE
a. Hospitals
b. Commercial/Private Laboratories
B. Physician Offices/Group Practices
1. MARKET SUMMARY
2. MARKET STRUCTURE
3. TEST VOLUME AND SALES FORECASTS
C. Ancillary Hospital Locations
1. INTRODUCTION
a. Emergency Departments
b. Operating Suites
c. Intensive Care Units
2. EMERGENCY DEPARTMENTS
a. Market Summary
b. Test volume and Sales Forecasts
3. OPERATING AND RECOVERY SUITES
a. Market Summary
b. Test Volume and Sales Forecasts
4. ICUS/CCUS
a. Market Summary
b. Test Volume and Sales Forecasts
D. Cancer Clinics 1. INTRODUCTION
2. MARKET SUMMARY
3. TEST VOLUME AND SALES FORECASTS
E. Ambulatory Care Centers 1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
F. Surgery Centers
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
G. Nursing Homes
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
H. Birth Centers
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
I. Major Suppliers’ Instrument Placements, Installed Base, Instrument and Consumables Sales, and Market Shares
MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
TESTING MARKETS
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Company Profile
Abbott
Agilent Technologies
Beckman Coulter/Danaher
Becton Dickinson
BioRad
CellaVision
Horiba
Iris Diagnostics/Danaher
Nihon Kohden
OrthoClinical Diagnostics
Roche
Siemens
Sysmex
LIST OF TABLES
U.S.A., Physician Office/Group Practice
Laboratories Forecast by Practice Size
U.S.A., Physician Offices/Group Practices
Forecast by Type
U.S.A., OfficeBased Physicians
Forecast by Practice Type
U.S.A., Physician Offices/Group Practices
Routine Hematology Test Volume Forecast
U.S.A., Physician Offices Laboratories
Flow Cytometry and Special Hematology Test Volume Forecast
U.S.A., Physician Offices/Group Practices
Hematology and Flow Cytometry Test Volume Forecast by Practice Type
U.S.A., Physician Offices/Group Practices
Hematology and Flow Cytometry Consumables
Market Forecast
U.S.A., Ancillary Hospital Locations Estimated Number
U.S.A., Ancillary Hospital Locations Annual Utilization
U.S.A., Hospital Emergency Departments
Routine Hematology Test Volume Forecast
U.S.A., Hospital Emergency Departments
Hematology Reagent Market Forecast
U.S.A., Hospital Operating and Recovery Suites
Routine Hematology Test Volume Forecast
U.S.A., Hospital Operating and Recovery Suites
Hematology Reagent Market Forecast
U.S.A., Hospital ICUs/CCUs Routine Hemagology Test Volume Forecast
U.S.A., Hospital ICUs/CCUs Hematology Reagent Market Forecast
U.S.A., Cancer Clinics Routine
Hematology/Flow Cytometry Test Volume Forecast
U.S.A., Cancer Clinics Hematology and Flow Cytometry Reagent Market Forecast
U.S.A., Ambulatory Care Centers Estimated
Number of Facilities and Patient Visits
U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
U.S.A., Ambulatory Care Centers Routine Hematology Test Volume Forecast
U.S.A., Ambulatory Care Centers Hematology Reagent Market Forecast
U.S.A., Surgery Centers Most
Frequently Performed Procedures
U.S.A., Surgery Centers
Routine Hematology Test Volume Forecast
U.S.A., Surgery Centers Hematology
Consumable Market Forecast
U.S.A., Nursing Homes Estimated Number of Facilities, Beds and Occupancy Rate
U.S.A., Nursing Homes
Routine Hematology Test Volume Forecast
U.S.A., Nursing Homes
Hematology Reagent Market Forecast
U.S.A., Birth Centers Facilities, Patient Visits, and Births
U.S.A., Birth Centers
Routine Hematology Test Volume Forecast
U.S.A., Birth Centers
Hematology Reagent Market Forecast
U.S.A., Hematology Analyzers
Estimated Placements and Installed Base
U.S.A., Flow Cytometers
Estimated Placements and Installed Base
U.S.A., Hematology Diagnostics Market
Estimated Market Shares of Major Suppliers
U.S.A., Hematology Instrument Market
Estimated Market Shares of Major Suppliers
U.S.A., Hematology Consumable Market
Estimated Market Shares of Major Suppliers
U.S.A., Flow Cytometry Diagnostics Market
Estimated Market Shares of Major Suppliers
U.S.A., Flow Cytometry Consumable Market
Estimated Market Shares of Major Suppliers
U.S.A., Flow Cytometry Instruments Market
Estimated Market Shares of Major Suppliers
U.S.A., Physician Office/Group Practice
Laboratories Forecast by Practice Size
U.S.A., Physician Offices/Group Practices
Forecast by Type
U.S.A., OfficeBased Physicians
Forecast by Practice Type
U.S.A., Physician Offices/Group Practices
Routine Hematology Test Volume Forecast
U.S.A., Physician Offices Laboratories
Flow Cytometry and Special Hematology Test Volume Forecast
U.S.A., Physician Offices/Group Practices
Hematology and Flow Cytometry Test Volume Forecast by Practice Type
U.S.A., Physician Offices/Group Practices
Hematology and Flow Cytometry Consumables
Market Forecast
U.S.A., Ancillary Hospital Locations Estimated Number
U.S.A., Ancillary Hospital Locations Annual Utilization
U.S.A., Hospital Emergency Departments
Routine Hematology Test Volume Forecast
U.S.A., Hospital Emergency Departments
Hematology Reagent Market Forecast
U.S.A., Hospital Operating and Recovery Suites
Routine Hematology Test Volume Forecast
U.S.A., Hospital Operating and Recovery Suites
Hematology Reagent Market Forecast
U.S.A., Hospital ICUs/CCUs Routine Hemagology Test Volume Forecast
U.S.A., Hospital ICUs/CCUs Hematology Reagent Market Forecast
U.S.A., Cancer Clinics Routine
Hematology/Flow Cytometry Test Volume Forecast
U.S.A., Cancer Clinics Hematology and Flow Cytometry Reagent Market Forecast
U.S.A., Ambulatory Care Centers Estimated
Number of Facilities and Patient Visits
U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
U.S.A., Ambulatory Care Centers Routine Hematology Test Volume Forecast
U.S.A., Ambulatory Care Centers Hematology Reagent Market Forecast
U.S.A., Surgery Centers Most
Frequently Performed Procedures
U.S.A., Surgery Centers
Routine Hematology Test Volume Forecast
U.S.A., Surgery Centers Hematology
Consumable Market Forecast
U.S.A., Nursing Homes Estimated Number of Facilities, Beds and Occupancy Rate
U.S.A., Nursing Homes
Routine Hematology Test Volume Forecast
U.S.A., Nursing Homes
Hematology Reagent Market Forecast
U.S.A., Birth Centers Facilities, Patient Visits, and Births
U.S.A., Birth Centers
Routine Hematology Test Volume Forecast
U.S.A., Birth Centers
Hematology Reagent Market Forecast
U.S.A., Hematology Analyzers
Estimated Placements and Installed Base
U.S.A., Flow Cytometers
Estimated Placements and Installed Base
U.S.A., Hematology Diagnostics Market
Estimated Market Shares of Major Suppliers
U.S.A., Hematology Instrument Market
Estimated Market Shares of Major Suppliers
U.S.A., Hematology Consumable Market
Estimated Market Shares of Major Suppliers
U.S.A., Flow Cytometry Diagnostics Market
Estimated Market Shares of Major Suppliers
U.S.A., Flow Cytometry Consumable Market
Estimated Market Shares of Major Suppliers
U.S.A., Flow Cytometry Instruments Market
Estimated Market Shares of Major Suppliers
